Cargando…

Long-lasting seropositivity after anti SARS-CoV-2 vaccination in pre liver transplant patients

Detalles Bibliográficos
Autores principales:	Calleri, Alberto, Saracco, Margherita, Romagnoli, Renato, Martini, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:	POSTER PRESENTATIONS: Saturday 25 June: Liver transplantation and hepatobiliary surgery: Clinical aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252405/ http://dx.doi.org/10.1016/S0168-8278(22)01867-0

Ejemplares similares

The impact of COVID-19 on the duration of the liver transplant process in patients presenting for inpatient liver transplant evaluation
por: Cooper, Katherine, et al.
Publicado: (2022)

Does m-RNA vaccination protect from Sars-Cov2 (asymptomatic) infection in liver transplant recipients?
por: Comandini, Ubaldo Visco, et al.
Publicado: (2022)

Third dose of SARS-COV2 mRNA-vaccine in liver transplant recipients: can it bridge the response gap?
por: Montalbano, Marzia, et al.
Publicado: (2022)

Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Impact of COVID-19 on the liver transplant activity in the US: variation by the region, etiology, and cirrhosis complications
por: Singal, Ashwani, et al.
Publicado: (2022)

SARS-CoV-2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2022)

Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients
por: Kounis, Ilias, et al.
Publicado: (2022)

SARS-CoV-2 infection in liver transplant recipients-a single center case series from Romania
por: Husar-Sburlan, Ioana-Alexandra, et al.
Publicado: (2022)

Humoral response to 2-dose BNT162b2 mRNA vaccine for COVID-19 in liver transplant recipients
por: Guarino, Maria, et al.
Publicado: (2022)

Sustainability of humoral immunity induced by the SARS-CoV-2 vaccine and response to booster dose among Liver Transplant recipients
por: Rabinowich, Liane, et al.
Publicado: (2022)

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients
por: Herrán, Aitor Odriozola, et al.
Publicado: (2022)

Liver transplant patients infection rate with SARS-CoV-2 is lower but depend upon the infection rate in the general population and have a better outcome
por: Cohen-Naftaly, Michal, et al.
Publicado: (2022)

Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients
por: Davidov, Yana, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Heterologous regimen viral-vector/mRNA produces significantly higher SARS-CoV-2 humoral response than homologous viral-vector and inactivated vaccines in liver transplant recipients
por: Mendizabal, Manuel, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) specific cellular and humoral immunity in Corovavirus Disease-2019 (COVID-19) convalescence after liver transplantation-a prospective six month follow-up
por: Kirchner, Theresa, et al.
Publicado: (2022)

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission
por: Mitchell, Robert A., et al.
Publicado: (2018)

Longevity of seropositivity after anti SARS-CoV-2 vaccination in patients awaiting liver transplant
por: Calleri, A., et al.
Publicado: (2022)

Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.
por: Sempere, Elena Diago, et al.
Publicado: (2022)

Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
por: Caicedo, Luis A., et al.
Publicado: (2017)

Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease
por: Mitchell, Jonathan, et al.
Publicado: (2023)

Understanding the Impact of Pneumonia and Other Complications in Elderly Liver Transplant Recipients: An Analysis of NSQIP Transplant
por: Schnickel, Gabriel T., et al.
Publicado: (2021)

The Changing Face of Liver Transplantation in the United States: The Effect of HCV Antiviral Eras on Transplantation Trends and Outcomes
por: Parrish, Nicholas F., et al.
Publicado: (2019)

Accessory Gallbladder Complicating Liver Transplantation
por: Kesseli, Samuel J., et al.
Publicado: (2018)

Long-term Outcome of Orthotopic Liver Transplantation in Patients With Hemochromatosis: A Summary of a 30-year Transplant Program
por: Dobrindt, Eva Maria, et al.
Publicado: (2020)

Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net
por: Pita, Alejandro, et al.
Publicado: (2019)

Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
por: Kato, Karin, et al.
Publicado: (2017)

Predictive Capacity of Risk Models in Liver Transplantation
por: de Boer, Jacob D., et al.
Publicado: (2019)

Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients
por: Hausken, John, et al.
Publicado: (2021)

The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study
por: Muduma, Gorden, et al.
Publicado: (2019)

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
por: Yamada, Yohei, et al.
Publicado: (2018)

The Effect and Safety of Prostaglandin Administration in Pediatric Liver Transplantation
por: Lironi, Céline, et al.
Publicado: (2017)

Liver Transplantation With Grafts From Super Obese Donors
por: Vargas, Paola A., et al.
Publicado: (2021)

Textbook Outcome as a Quality Metric in Liver Transplantation
por: Schenk, Austin D., et al.
Publicado: (2022)

Splenic Artery Transposition for Liver Transplantation: An Underutilized Technique?
por: Goss, Matthew B., et al.
Publicado: (2021)

Acute on Chronic Liver Failure: Factors Associated With Transplantation
por: Goussous, Naeem, et al.
Publicado: (2021)

Liver Transplant Outcomes in Patients With Postcapillary Pulmonary Hypertension
por: Kleb, Cerise, et al.
Publicado: (2022)

Contemporary Management of Median Arcuate Ligament in Liver Transplantation
por: Babu, Benoy I., et al.
Publicado: (2022)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hrs32tjmd2qtu4spd5ii6ii3rt